Patent · US Active

Gene expression profiles being predictive for the response of tumors to pharmaceutically effective compounds

US8691506B2 · kind B2 · utility

0Cited by

0References

5Claims

0Family size

Assignee

Oncotest GmbH · DE

Inventors

Niko Bausch · Glückstadt, DE
Heinz-Herbert Fiebig · Glückstadt, DE
André Korrat · Glückstadt, DE
Martina Maurer · Glückstadt, DE
Thomas Metz · Kennewick, US
Julia Schüler · Glückstadt, DE

Key dates

Filing date	Apr 13, 2006
Grant date	Apr 8, 2014
Priority date	—
Expiry date	Feb 4, 2031

Classification

Technology area (CPC G)Physics
CPC primaryG16B25/00
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to a method for providing a gene expression profile being predictive for the specific response of an individual tumor to a pharmaceutically effective compound, the use thereof, a microarray wherein the nucleotide sequences attached to the substrate consist of nucleotide sequences corresponding to the predictive genes of said gene expression profile, and a diagnostic kit containing said microarray.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.